Search Press releases Keywords From To 20 Apr 2023 UCB Showcases Strength and Depth of Neurology Portfolio at 75th American Academy of Neurology (AAN) Annual Meeting Read More 13 Apr 2023 UCB’s Rozanolixizumab and Zilucoplan Phase 3 Generalized Myasthenia Gravis studies published in prestigious The Lancet Neurology Journal Read More 24 Mar 2023 Acquisition of own shares Read More 18 Mar 2023 Bimekizumab Phase 3 Data in Hidradenitis Suppurativa Show Clinically Meaningful, Deep and Maintained Response over 48 Weeks Read More 17 Mar 2023 Acquisition of own shares Read More 16 Mar 2023 UCB to Present Eight Bimekizumab Abstracts at AAD 2023 with Results from Studies in Psoriasis, Psoriatic Arthritis and Hidradenitis Suppurativa Read More Pagination First page Previous page Previous … Page 30 Page 31 Page 32 Page 33 Current page 34 Page 35 Page 36 Page 37 Page 38 … Page 34 of 63 Next page Next Last page Stay up-to-date on the latest news and information from UCB Subscribe
